Get started
Author

Fanny Escudié

Observed names: Fanny B. Escudié, Fanny Escudie
ORCID: 0000-0002-9177-9755
Observed ORCID: 0000-0002-9177-9755
OpenAlex ID: A5022250671
The oral protease inhibitor (PF-07321332) protects Syrian hamsters against infection with SARS-CoV-2 variants of concern
2022 · Rana Abdelnabi, Caroline S. Foo, et al. · Nature Communications · 123
PDF
The antimalarial MMV688533 provides potential for single-dose cures with a high barrier to Plasmodium falciparum parasite resistance
2021 · James M. Murithi, Cécile Pascal, et al. · Science Translational Medicine · 49
PDF
Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains
2024 · Hawa Sophia Bouzidi, Jean-Sélim Driouich, et al. · Antiviral Research · 28
Pre-clinical evaluation of antiviral activity of nitazoxanide against SARS-CoV-2
2022 · Jean-Sélim Driouich, Maxime Cochin, et al. · EBioMedicine · 21
PDF
Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens
2024 · Irfan Ullah, Fanny Escudie, et al. · iScience · 12
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
2022 · Frauke Assmus, Jean-Sélim Driouich, et al. · Microorganisms · 11
PDF
Implementation and continued validation of the malaria Plasmodium falciparum lactate dehydrogenase-based colorimetric assay for use in antiplasmodial drug screening
2022 · Patrick Valere Tsouh Fokou, Brice Mariscal Tchatat Tali, et al. · Analytical Biochemistry · 11
PDF
Lack of antiviral activity of probenecid in vitro and in Syrian golden hamsters
2023 · Helen J Box, Joanne Sharp, et al. · Journal of Antimicrobial Chemotherapy · 7
PDF
Preclinical data do not support the use of amiodarone or dronedarone as antiparasitic drugs for Chagas disease at the approved human dosing regimen
2023 · Amanda F. Francisco, Gong Chen, et al. · Frontiers in Tropical Diseases · 5
Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas disease
2025 · Frauke Assmus, Ayorinde Adehin, et al. · PLoS neglected tropical diseases · 3
PDF
In Vivo Bioluminescence Imaging Reveals Differences in Leishmania infantum Parasite Killing Kinetics by Antileishmanial Reference Drugs
2024 · Sarah Hendrickx, Pim-Bart Feijens, et al. · ACS Infectious Diseases · 3
Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns
2024 · Paul-Rémi Petit, Franck Touret, et al. · Heliyon · 3
Transcriptomic and proteomic analysis of quiescent epimastigotes as a resource for investigating Trypanosoma cruzi persistence
2026 · Francisco Olmo, Amy Hesketh, et al. · Communications Biology
PDF
Overcoming Trypanosoma cruzi persistence with a mechanistically distinct drug combination
2026 · Amanda Fortes Francisco, Francisco Olmo, et al. · npj Antimicrobials and Resistance
PDF
An MRC-5 cell based high-throughput, high-content imaging assay to identify hits against Trypanosoma cruzi intracellular parasites
2026 · Bilal Zulfiqar, Melissa L. Sykes, et al. · SLAS DISCOVERY
Works count: 15
Citation count: 276
H-index: 7
I10-index: 7
Year
Topic
Type